MHRA fees
Fees payable to the MHRA from 2025.
Documents
Details
The document attached lists MHRA fees from 2025. It incorporates new EU Exit fees which came into force on 1 January 2021.
For further information on EU Exit fees see .
Updates to this page
-
Updated fees payable to the MHRA from 2025.
-
Updated to include fees regarding International Recognition.
-
Amendment fees added to our 'Current MHRA fees' webpage.
-
Added links to Fees page: The Medicines (Products for Human Use) (Fees) (Amendment) Regulations 2023 & The Medical Devices and Blood Safety and Quality (Fees Amendment) Regulations 2023
-
Updated MHRA fees for 2023 - 2024
-
Added link to application form to 'apply for Small and Medium Company status'.
-
CURRENT FEES UPDATED
-
Changes to MHRA fees for 2021 - 2022
-
Published a new version of the 'Payment Easements and Waivers for Small and Medium Companies, as a HTML document. This replaces the 'Payment Easements for Small Companies' PDF.
-
Update on the MHRA fees for Licence applications: marketing authorisations; Orphan Marketing Products: fees; Variations: licence variations application fees; Variations: licence variations applications groups fees; and Variations: Traditional Herbal Registration Scheme fees
-
Added new information on fees following the end of the transition period. This includes new sections on orphan marketing products, Pharmacovigilance (PV) Safety Reviews, pre-assessment (rolling review) fees, PMF and Vaccine Antigen Master File certification.
-
Amended text under 'Current MHRA fees' guidance. Section '13. Inspection: fees'.
-
We have updated the years references to the periodic fees
-
Update to confirm fee levels for 2020 to 2021 are remaining the same as 2019 to 2020
-
Minor amendment to the explanation of the Office Based Inspection Fee to include information that was left out by mistake.
-
Information about 2017/18 fees added to the page.
-
MHRA's fees changed on April 1 2016.
-
MHRA's fees change on April 1 2016. Uploaded a PDF of the changed fees.
-
First published.